LEADER 02297nam  2200433   450 
001 9910138348103321
005 20240126194102.0
010   $a953-51-6519-4
035   $a(CKB)3230000000075554
035   $a(NjHacI)993230000000075554
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/65206
035   $a(EXLCZ)993230000000075554
100   $a20221010d2011      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAortic stenosis /$fetiology, pathophysiology and treatment
210   $cIntechOpen$d2011
210  1$a[Place of publication not identified] :$cInTech,$d[2011]
210  4$dİ2011
215   $a1 online resource (266 pages) $cillustrations
311   $a953-307-660-7 
320   $aIncludes bibliographical references.
330   $aCurrently, aortic stenosis (AS) is the most prevalent valvular disease in developed countries. Pathological and molecular mechanisms of AS have been investigated in many aspects. And new therapeutic devices such as transcatheter aortic valve implantation have been developed as a less invasive treatment for high-risk patients. Due to advanced prevalent age of AS, further discovery and technology are required to treat elderly patients for longer life expectancy. This book is an effort to present an up-to-date account of existing knowledge, involving recent development in this field. Various opinion leaders described details of established knowledge or newly recognized advances associated with diagnosis, treatment and mechanism. Thus, this book will enable close intercommunication to another field and collaboration technology for new devices. We hope that it will be an important source, not only for clinicians, but also for general practitioners, contributing to development of better therapeutic adjuncts in the future.
517   $aAortic Stenosis
606   $aAortic valve
610   $aEndocrinology
615  0$aAortic valve.
676   $a612.12
700   $aHirota$b Masanori$01263249
702   $aHirota$b Masanori$4oth
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910138348103321
996   $aAortic stenosis$92960388
997   $aUNINA